WATSON 151 4 mg (Rapaflo 4 mg)

Generic Name: silodosin

Pill imprint WATSON 151 4 mg has been identified as Rapaflo 4 mg.

Rapaflo is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Rapaflo 4 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 151 4 mg

Rapaflo 4 mg WATSON 151 4 mg
Rapaflo
Generic Name:
silodosin
Imprint:
WATSON 151
4 mg
Strength:
4 mg
Color:
White
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0151

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)